Skip to content

Dri Cotinine Eia Assay

by Microgenics Corporation

510(k) K030649

Active European Union and United States

CE IVDD 510(k)

Valid until

No date given

CE: no date in EUDAMED. FDA: not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

None linked in EUDAMED

A group certificate may exist

Trust

Unverified

Source EUDAMED, FDA 510(k), synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE 510(k) Substantially Equivalent · Traditional NumberK030649 Date22 May 2003ClearedStatusActive
European UnionCE/IVDD EUDAMED Number— Date—StatusActive

Official records

From the FDA record

Received by the FDA
28 Feb 2003
FDA decision
22 May 2003 (Substantially Equivalent)
FDA review time
83 days from receipt to decision
Public document
510(k) summary on file with the FDA

From the FDA 510(k) record K030649 (openFDA), as read on 22 Oct 2026. Quoted as published, gaps included; nothing on this list is generated.

Across registries

2 registries list this device

  • FDA 510(k) K030649 decided 22 May 2003 Active
  • EUDAMED Active

Coverage

2 jurisdictions

United States of AmericaSwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered
  • European Union CE/IVDD Active
  • United States FDA 510(k) Active

Specification

EUDAMED · 510(k)

510(k) Number
FDA product code
MRS
FDA applicant
Microgenics Corp.
Device class
Class I
Regulation
21 CFR Part 862.3220
Advisory committee
Clinical Toxicology
FDA decision
SESE Substantially Equivalent

Overview

AI-generated summary, 25 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Dri Cotinine Eia Assay is a liquid ready-to-use homogeneous enzyme immunoassay that uses specific antibodies to detect cotinine in urine. It is based on competition between a drug labeled with glucose-6-phosphate dehydrogenase enzyme and free drug from the urine sample for a fixed amount of specific antibody binding sites. The assay is intended for in vitro diagnostic use only.

The Dri Cotinine Eia Assay is intended for the qualitative and semi-quantitative determination of cotinine in human urine at a cutoff level of 500 ng/mL. It is supplied as a liquid, ready-to-use homogeneous enzyme immunoassay and is regulated under FDA 510(k) and IVDD authorizations.

Similar devices

Other devices filed under FDA product code MRS (Test System, Nicotine, Cotinine, Metabolites).

Other devices from Microgenics Corporation

See all devices from Microgenics Corporation →